A patient with persistent chest pain and previous mitral valve replacement had no recurrence of pain once target international normalized ratio was reached.
Joshua Mercado- Maldonado and Jaime Rivera-Babilonia are PGY-5 Cardiology Fellows, Javier Mirabal is a PGY-6 Cardiology Fellow, and Eric Aviles is a Staff Cardiologist, all at VA Caribbean Healthcare System in San Juan, Puerto Rico. Correspondence: Joshua Mercado-Maldonado (joshua9288@hotmail.com)
Author disclosures The authors report no actual or potential conflicts of interest with regard to this article.
Disclaimer The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the US Government, or any of its agencies. This article may discuss unlabeled or investigational use of certain drugs. Please review the complete prescribing information for specific drugs or drug combinations—including indications, contraindications, warnings, and adverse effects—before administering pharmacologic therapy to patients.
A 74-year-old male veteran presented at an urgent care clinic in Aguadilla, Puerto Rico, with a sharp, nonradiating, left-sided precordial chest pain that started while cleaning his house and gardening. The patient described the pain as 9 on the 10-point Wong-Baker FACES Pain Rating Scale, lasting about 5 to 10 minutes and was alleviated with rest. The patient’s medical history consisted of multiple comorbidities, including a mitral valve replacement with a Star-Edwards valve (ball in cage) in 1987. The electrocardiogram performed at the clinic showed no acute ischemic changes. Due to the persistent pain, the patient was transferred to Veterans Affairs Caribbean Healthcare System in San Juan, Puerto Rico, for further evaluation and management. On arrival, the patient had an international normalized ratio (INR) of 2.22; elevated high-sensitive troponin enzyme readings of 56 ng/L at 6:38 PM (0h); 61 ng/L at 7:38 PM (1h); and 83 ng/L at 9:47 PM (3h), reference range, 0-22 ng/L, and changes that prompted admission to the cardiac critical care unit. Two days later, a follow-up enzyme level was 52 ng/L. Cardiac catheterization revealed an acute filling defect at mid-left anterior descending artery and remaining coronary arteries with < 25% atherosclerosis (Figure). A myocardial perfusion study was performed for myocardial viability. The results showed a small, reversible perfusion defect involving the apical-septal wall with the remaining left ventricular myocardium appearing viable. Aspirin was added to the patient’s anticoagulation regimen of warfarin. Once target INR was reached, the patient was discharged home without recurrence of angina.